# A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization

> **NCT01941446** · PHASE1 · COMPLETED · sponsor: **Tetraphase Pharmaceuticals, Inc** · enrollment: 54 (actual)

## Conditions studied

- Normal Healthy Subjects

## Interventions

- **DRUG:** Eravacyline, Moxifloxacin, and placebo

## Key facts

- **NCT ID:** NCT01941446
- **Lead sponsor:** Tetraphase Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-06
- **Final completion:** 2013-07
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2021-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01941446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01941446, "A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01941446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*